Financials
Reported figures only · latest: Q2 2026
USD · IFRS
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income11 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | $17.2M | −$102.1M |
|---|
| FY24 | $5.9M | −$88M |
|---|
| FY23 | $7.5M | −$81.9M |
|---|
| FY22 | $10.2M | −$91.3M |
|---|
| FY21 | $7.4M | −$98.8M |
|---|
| FY20 | $32.2M | −$77.9M |
|---|
| FY19 | $16.7M | −$89.8M |
|---|
| FY18 | $17.3M | −$35.3M |
|---|
| FY17 | $2.4M | −$76.8M |
|---|
| FY16 | $42.5M | −$4.1M |
|---|
| FY15 | - | - |
|---|
MarginsShare of revenueShow the numbers
| Year | Gross margin | Net margin |
|---|
| FY25 | 70.2% | −593.9% |
|---|
| FY24 | 100% | −1490.3% |
|---|
| FY23 | 100% | −1091.7% |
|---|
| FY22 | - | −894.6% |
|---|
| FY21 | - | −1329.2% |
|---|
| FY20 | - | −242.4% |
|---|
| FY19 | - | −537% |
|---|
| FY18 | - | −203.5% |
|---|
| FY17 | - | −3184.7% |
|---|
| FY16 | - | −9.7% |
|---|
| FY15 | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | −$50.6M |
|---|
| FY24 | −$48.7M |
|---|
| FY23 | −$63.5M |
|---|
| FY22 | - |
|---|
| FY21 | - |
|---|
| FY20 | - |
|---|
| FY19 | - |
|---|
| FY18 | - |
|---|
| FY17 | - |
|---|
| FY16 | - |
|---|
| FY15 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- Mesoblast
- Healthcare median
Show the numbers
| Year | Mesoblast | Healthcare median |
|---|
| FY25 | −593.9% | −30.6% |
|---|
| FY24 | −1490.3% | −47% |
|---|
| FY23 | −1091.7% | −58% |
|---|
| FY22 | −894.6% | −80.4% |
|---|
| FY21 | −1329.2% | −71.9% |
|---|
| FY20 | −242.4% | −62.2% |
|---|
| FY19 | −537% | −46.3% |
|---|
| FY18 | −203.5% | −49.6% |
|---|
| FY17 | −3184.7% | −45.9% |
|---|
| FY16 | −9.7% | −36% |
|---|
| FY15 | - | −38.4% |
|---|